EVALUATION OF A MODIFIED BIOMATERIAL OF TYMPANOTONUS FUSCATA SHELL POWDER II: FORMULATION OF PYRIMETHAMINE AND PYRIDOXINE HYDROCHLORIDE TABLETS

Journal Title: Journal of Drug Delivery and Therapeutics - Year 2018, Vol 8, Issue 2

Abstract

A novel modified biomaterial of periwinkle shell powder, MBPSP was developed from Tympanotonus fuscata. It was assessed as a bulking agent in the formulation of pyrimethamine and pyridoxine hydrochloride tablets adopting dicalcium phosphate dihydrate (DCP) as a standard. A 100 g of the ground periwinkle shell was broken down in 166.0 ml of 2 M hydrochloric acid, clarified and treated with 5 M sodium hydroxide. The thick white precipitate obtained was washed severally and to it, ortho-phosphoric acid was dropped in bits until a thick, dehydrated bulk was attained which was dried at 60 o C and classified with 250 μm sieve. The product was coded MBPSP. Two batches of granules containing pyrimethamine (25 mg) and pyridoxine hydrochloride (50 mg) were generated by the wet granulation employing MBPSP alongside DCP. The granules were lubricated with magnesium stearate and talc and compacted into tablets at 7.55kN using a 10.50 mm diameter die and flat-faced punch fixed in a hydraulic hand press. The tablet produced were evaluated using the British Pharmacopoeia specifications. The weight variation for the pyrimethamine or pyridoxine hydrochloride tablets containing MBPSP or DCP were 0.06, 0.1, 0.097 and 0.143 % respectively. The total drug content for the individual lots of tablets for either pyrimethamine or pyridoxine hydrochloride was within 85.00-115.00 % of their label claim. Higher mechanical strength were noted for the batch of tablets manufactured with DCP and containing pyrimethamine and pyridoxine hydrochloride than MBPSP. Though the entire batches of tablets for the two drugs manufactured with either MBPSP or DCP disintegrated in less than 5.00 min with no significant difference in their individual disintegrating time (p>0.05), pyridoxine hydrochloride tablets prepared with DCP disintegrated in lesser time when compared to MBPSP (p<0.05). Only the pyrimethamine tablets prepared with MBPSP attained 75.00 % drug release in 45.00 min in line with the United States Pharmacopoeia (USP) criteria. Therefore, MBPSP could be another very useful bulking agent in the formulation of pyrimethamine immediate-release tablets by the wet granulation technique. Keywords: Modified biomaterial, Tympanotonus fuscata, periwinkle, shell, pyrimethamine, pyridoxine hydrochloride, tablet.

Authors and Affiliations

Keywords

Related Articles

Study on Anti-inflammatory and Analgesic Effect of FangXiangTongLuo-cervical Plaster

Objective: To study the anti-inflammatoryandanalgesic effects of FangXiangTongLuo-cervical Plaster. Methods: Preparation of FangXiangTongLuo cervical ointment. Using the model of the mouse ear swelling inflammation whic...

Antibacterial, antifungal and antioxidant activity of Dichapetalum gelonioides (Roxb.) Engl. (Dichapetalaceae)

Objectives: Dichapetalum gelonioides (Roxb.) Engl. belongs to the family Dichapetalaceae. In the present study, we investigated antibacterial, antifungal and antioxidant activity of methanolic extract of leaf and fruit o...

EVALUATION OF ANTI PSORIATIC ACTIVITY OF KARANJIN OIL

Psoriasis is defined as a type of severe inflammatory and autoimmune skin disease, caused due to genetic and natural/surrounding factors and the most successful way to tackle this disease is topical treatment. To examine...

FORMULATION AND EVALUATION OF PULSATILE DRUG DELIVERY SYSTEMS OF GLIPIZIDE FOR THE MANAGEMENT OF TYPE-II DIABETES MELLITUS

The objective of the present study was to fabricate and evaluate a chronomodulated pulsatile drug delivery system to maintain the blood glucose level by releasing the drug at a predetermined time interval. The basic desi...

BENEFIT OF TOPIRAMATE IN THE TREATMENT OF SYMPTOMS OF BORDERLINE PERSONALITY DISORDER: A TYPICAL REVIEW

Topiramate is a new antiepileptic drug (AED) that has been approved worldwide (in more than 80 countries) for the treatment of various kinds of epilepsy. It is currently being evaluated for its effect in various neurolog...

Download PDF file
  • EP ID EP479334
  • DOI 10.22270/jddt.v8i2.1709
  • Views 75
  • Downloads 0

How To Cite

(2018). EVALUATION OF A MODIFIED BIOMATERIAL OF TYMPANOTONUS FUSCATA SHELL POWDER II: FORMULATION OF PYRIMETHAMINE AND PYRIDOXINE HYDROCHLORIDE TABLETS. Journal of Drug Delivery and Therapeutics, 8(2), 188-193. https://europub.co.uk/articles/-A-479334